Call Options

20 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$0.77 - $1.04 $18,326 - $24,752
23,800 Added 136.78%
41,200 $31,000
Q2 2024

Aug 14, 2024

SELL
$0.76 - $1.79 $1,596 - $3,759
-2,100 Reduced 10.77%
17,400 $14,000
Q1 2024

May 15, 2024

SELL
$0.37 - $0.72 $518 - $1,008
-1,400 Reduced 6.7%
19,500 $13,000
Q4 2023

Feb 14, 2024

BUY
$0.67 - $1.17 $2,010 - $3,510
3,000 Added 16.76%
20,900 $15,000
Q3 2023

Nov 15, 2023

BUY
$0.72 - $1.33 $12,888 - $23,807
17,900 New
17,900 $12,000
Q1 2023

May 15, 2023

BUY
$1.16 - $6.41 $927 - $5,128
800 Added 1.56%
52,100 $63,000
Q4 2022

Feb 14, 2023

SELL
$4.78 - $15.01 $630,960 - $1.98 Million
-132,000 Reduced 72.01%
51,300 $271,000
Q3 2022

Nov 14, 2022

BUY
$10.22 - $23.7 $473,186 - $1.1 Million
46,300 Added 33.8%
183,300 $2.15 Million
Q2 2022

Aug 15, 2022

BUY
$4.35 - $15.85 $469,364 - $1.71 Million
107,900 Added 370.79%
137,000 $1.57 Million
Q1 2022

May 16, 2022

SELL
$4.55 - $6.41 $122,850 - $173,070
-27,000 Reduced 48.13%
29,100 $144,000
Q4 2021

Feb 14, 2022

SELL
$5.89 - $9.73 $16,492 - $27,244
-2,800 Reduced 4.75%
56,100 $337,000
Q3 2021

Nov 12, 2021

BUY
$6.78 - $9.89 $48,816 - $71,208
7,200 Added 13.93%
58,900 $502,000
Q2 2021

Aug 06, 2021

SELL
$7.24 - $11.2 $376,480 - $582,400
-52,000 Reduced 50.14%
51,700 $430,000
Q1 2021

May 14, 2021

BUY
$8.05 - $20.78 $198,030 - $511,188
24,600 Added 31.1%
103,700 $1.14 Million
Q4 2020

Feb 12, 2021

BUY
$2.36 - $9.99 $150,332 - $636,363
63,700 Added 413.64%
79,100 $680,000
Q3 2020

Nov 13, 2020

BUY
$2.58 - $3.36 $7,482 - $9,744
2,900 Added 23.2%
15,400 $40,000
Q2 2020

Aug 13, 2020

SELL
$3.01 - $4.02 $16,555 - $22,109
-5,500 Reduced 30.56%
12,500 $43,000
Q1 2020

May 11, 2020

BUY
$2.58 - $4.58 $46,440 - $82,440
18,000 New
18,000 $59,000
Q4 2019

Feb 12, 2020

SELL
$1.86 - $3.35 $22,134 - $39,865
-11,900 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$1.81 - $2.36 $21,539 - $28,084
11,900 New
11,900 $25,000

Others Institutions Holding VERU

About VERU INC.


  • Ticker VERU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 80,146,704
  • Market Cap $56.9M
  • Description
  • Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....
More about VERU
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.